Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
Gastroenterology|May 8, 2009
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with menThijis van de Laar, Oliver Pybus, Sylvia Bruisten, et al.
Drug and Alcohol Dependence|June 30, 2022
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage StudyAlice Wheeler, Heather Valerio, Evan B Cunningham, et al.
Nucleic Acids Research|April 19, 2013
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerizationAntonio Ariza, Sian J Tanner, Cheryl T Walter, et al.
Journal of Hepatology|October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trialGregory J Dore, Jordan J Feld, Alex Thompson, et al.
The International Journal on Drug Policy|March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P studyAnna Conway, Jason Grebely, Shane Tillakeratne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International StudyAndreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist TherapyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Cell Reports. Medicine|December 3, 2024
Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE studyWin Min Han, Hossain M S Sazzad, Mark Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject DrugsEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
HIV Research & Clinical Practice|August 8, 2022
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D<sup>2</sup>EFTEmmanuelle Papot, Simone Jacoby, Dona Arlinda, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
Gastroenterology|May 8, 2009
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with menThijis van de Laar, Oliver Pybus, Sylvia Bruisten, et al.
Drug and Alcohol Dependence|June 30, 2022
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage StudyAlice Wheeler, Heather Valerio, Evan B Cunningham, et al.
Nucleic Acids Research|April 19, 2013
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerizationAntonio Ariza, Sian J Tanner, Cheryl T Walter, et al.
Journal of Hepatology|October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trialGregory J Dore, Jordan J Feld, Alex Thompson, et al.
The International Journal on Drug Policy|March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P studyAnna Conway, Jason Grebely, Shane Tillakeratne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International StudyAndreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist TherapyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Cell Reports. Medicine|December 3, 2024
Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE studyWin Min Han, Hossain M S Sazzad, Mark Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject DrugsEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
HIV Research & Clinical Practice|August 8, 2022
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D<sup>2</sup>EFTEmmanuelle Papot, Simone Jacoby, Dona Arlinda, et al.
Pageof 30